HIV/Hep C in Rural Communities Affected by Opioid Injection Epidemics (Deadline 1/10/17)
Fund Title
HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)
Fund Number
5212
Description
This FOA will support biphasic (i.e., two stage, multi-method) research projects that inform community response and promote comprehensive, integrated approaches to prevent HIV and hepatitis C virus (HCV) infection, along with associated comorbidities such as hepatitis B virus (HBV) infection and sexually transmitted diseases (STDs), among people who inject drugs (PWID) in rural US communities. Opioid injection and its consequences (e.g., HIV, HCV, HBV, STDs and overdose) are the primary foci here. These projects should yield evidence of the effectiveness of community response models and best practices in responding to opioid injection epidemics that can be implemented by public health systems in similar rural communities in the US.
Sponsor(s)
- US Department of Health and Human Services
- National Institutes of Health
— AND —
- US Department of Health and Human Services
- Public Health Service
- Substance Abuse and Mental Health Services Administration
- Center for Substance Abuse Prevention
— AND —
- National Center for US Department of Health and Human Services
- Public Health Service
- Centers for Disease Control and Prevention
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
Web Page
grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-014.html
Letter of Intent Date
12/10/2017
Application Due Date
01/10/2017
Fund Duration
The maximum project period is 5 years: up to 2 years for the first phase (UG3) and up to 3 years for the second phase (UH3).
Application Process
It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Number of Awards
Varies
Total Award
$6,500,000.00
Eligible Locations
National
Application Contact Name
Richard Jenkins PhD
Application Contact Address
United States
Phone
301-443-1923
Technical Contact Name
Title
GrantsInfo
Technical Contact Address
United States
Phone
301-710-0267
Eligibility
- Colleges/Universities
- County Agencies
- Federal Government Agencies
- IRS 501 (c)(3) Organizations
- Minority Owned Organizations
- Nonprofit Organizations
- Religious Organizations
- Research Institutions
- State Agencies
- Tribal Organizations
- Woman Owned Organizations
Last Updated on February 13, 2018 by HepFree NYC
Tags: Grant Hepatitis B Hepatitis C & HIV Opioids Substance Abuse
){kind=link}